in this issue
Regions :: North America :: U.S.
Informex 2013: Bright outlook for US API manufacturing
12:26 PM MST | February 22, 2013 | Rebecca Coons in Anaheim
Drug companies looking for speedy turnaround and strong intellectual property (IP) protection for active pharmaceutical ingredient (API) production are moving away from low-cost emerging market firms, lifting prospects for US-based producers, according to attendees of Informex, currently underway in Anaheim, CA. “Cost is an important factor and always will be,” said Aslam Malik, president of Ampac Fine Chemicals. “But customers are looking at other attributes, like communication, the legal system, the culture, the service...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee